AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Noji, Y Kajinami, K Kawashiri, M Todo, Y Horita, T Nohara, A Higashikata, T Inazu, A Koizumi, J Takegoshi, T Mabuchi, H
Citation: Y. Noji et al., Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis, CLIN CH L M, 39(5), 2001, pp. 380-384

Authors: Higashikata, T Koyama, J Shimada, H Yazaki, M Owa, M Ikeda, S
Citation: T. Higashikata et al., An 80-year-old mitochondrial disease patient with A3243G tRNA(Leu) ((UUR))gene presenting cardiac dysfunction as the main symptom, INTERN MED, 40(5), 2001, pp. 405-408

Authors: Kido, Y Tsuru, T Park, JO Higashikata, T Kaneda, Y Kono, Y
Citation: Y. Kido et al., Three-dimensional overview of the Japan Trench - an example of using the Frontier database system, COMPUT GEOS, 27(1), 2001, pp. 43-57

Authors: Mabuchi, H Nohara, A Higashikata, T Inazu, A
Citation: H. Mabuchi et al., Treatment of familial hypercholesterolaemia, EUR H J SUP, 2(D), 2000, pp. D65-D67

Authors: Owa, M Higashikata, T Shimada, H Kitahara, H Asano, M Nakayama, J Hikita, H Koyama, J Sakurai, S Ikeda, S
Citation: M. Owa et al., Primary cardiac malignant fibrous histiocytoma in the right ventricular infundibulum treated with a cavo-pulmonary shunt and coronary embolization, JPN CIRC J, 64(12), 2000, pp. 982-984

Authors: Nozue, T Nohara, A Higashikata, T Inazu, A Mabuchi, H Kajinami, K Koizumi, J
Citation: T. Nozue et al., Additive effects of another kind of HMG-CoA reductase inhibitor with different pharmacokinetics in the treatment of heterozygous familial hypercholesterolemia, ATHEROSCLER, 153(2), 2000, pp. 525-526

Authors: Yazaki, M Tokuda, T Nakamura, A Higashikata, T Koyama, J Higuchi, K Harihara, Y Baba, S Kametani, F Ikeda, S
Citation: M. Yazaki et al., Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin, BIOC BIOP R, 274(3), 2000, pp. 702-706

Authors: Koyama, J Owa, M Sakurai, S Shimada, H Hikita, H Higashikata, T Ikeda, S
Citation: J. Koyama et al., Relation between vascular morphologic changes during stent implantation and the magnitude of in-stent neointimal hyperplasia, AM J CARD, 86(7), 2000, pp. 753-758
Risultati: 1-8 |